Skip to main content
Top
Published in: Rheumatology International 7/2011

01-07-2011 | Original Article

The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis

Authors: Ayşe Dicle Turhanoğlu, Hayal Güler, Zafer Yönden, Fatma Aslan, Ayhan Mansuroglu, Cahit Ozer

Published in: Rheumatology International | Issue 7/2011

Login to get access

Abstract

We aimed to establish the relationship between serum vitamin D levels and disease activity and health status in rheumatoid arthritis. Sixty-five patients with RA fulfilling ACR criteria for the classification of rheumatoid arthritis and forty healthy controls were included in this study. Disease activity was assessed according to the Disease Activity Score including 28 joint counts. C-reactive protein (CRP, mg/dl) was determined by the nephelometric method. Erythrocyte sedimentation rate (ESR, mm/h) was determined by the Westergren method. Rheumatoid factor (RF, IU/ml) was also determined by the nephelometric method, and RF > 20 IU/ml was defined as positive. 25-OH Vitamin D EIA Kit was used to measure serum 25-OH Vitamin D levels. We found that the mean of the 25-OH D vitamin levels of the patients with RA was not different than that of controls (P = 0.936). We divided patients with RA into three groups according to DAS28 as low activity group (group 1, n = 25), moderate activity group (group 2, n = 25), and high activity group (group 3, n = 15). 25-OH vitamin D levels of the patients in the high activity group (group 3) were found to be the lowest (P < 0.001), and the patients with moderate disease activity had lower levels than those in the mild group (P = 0.033). Serum 25-OH vitamin D levels were significantly negatively correlated with DAS28, CRP, and HAQ (respectively, r = −0.431, P = 0.000, r = −0.276, P = 0.026, and r = −0.267, P = 0.031). Serum vitamin D levels in patients with RA were similar those in the healthy controls, while it significantly decreases in accordance with the disease activity and decreasing functional capacity.
Literature
1.
go back to reference Firestein GS (2005) Etiology and pathogenesis of rheumatoid arthritis. In: Harris ED, Budd RC, Sargent JS, Sledge CB, Ruddy S (eds) Kelley’s textbook of rheumatology. Elsevier Saunders, Philadelphia, pp 996–1042 Firestein GS (2005) Etiology and pathogenesis of rheumatoid arthritis. In: Harris ED, Budd RC, Sargent JS, Sledge CB, Ruddy S (eds) Kelley’s textbook of rheumatology. Elsevier Saunders, Philadelphia, pp 996–1042
2.
go back to reference Sokka T (2005) Rheumatoid arthritis data bases in Finland. Clin Exp Rheumatol 23(Suppl 39):201–204 Sokka T (2005) Rheumatoid arthritis data bases in Finland. Clin Exp Rheumatol 23(Suppl 39):201–204
3.
go back to reference Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142PubMedCrossRef Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142PubMedCrossRef
4.
go back to reference Cutalo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in Rheumatoid arthritis. Autoimmun Rev 7:59–64CrossRef Cutalo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in Rheumatoid arthritis. Autoimmun Rev 7:59–64CrossRef
5.
go back to reference Arnett FC, Edworthy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
6.
go back to reference Van Gestel AM, Haagsma CJ, van Riel PL (1988) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850 Van Gestel AM, Haagsma CJ, van Riel PL (1988) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850
7.
8.
go back to reference Hollick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373CrossRef Hollick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373CrossRef
9.
go back to reference Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80:1717–1720 Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80:1717–1720
10.
go back to reference Harel M, Shoenfeld Y (2006) Predicting and preventing autoimmunity, myth or reality? Ann NY Acad Sci 1069:322–345PubMedCrossRef Harel M, Shoenfeld Y (2006) Predicting and preventing autoimmunity, myth or reality? Ann NY Acad Sci 1069:322–345PubMedCrossRef
11.
go back to reference Costenbader KH, Feskanich D, Benito-Garcia E, Holmas M, Karlson E (2007) Vitamin d intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 31:446–447 Costenbader KH, Feskanich D, Benito-Garcia E, Holmas M, Karlson E (2007) Vitamin d intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 31:446–447
12.
go back to reference Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143–2149PubMedCrossRef Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D (2007) Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 56:2143–2149PubMedCrossRef
13.
go back to reference Orbach H, Zandman-Goddard G, Amital H et al (2007) Novel biomarkers in autoimmune diseases; prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385–400PubMedCrossRef Orbach H, Zandman-Goddard G, Amital H et al (2007) Novel biomarkers in autoimmune diseases; prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385–400PubMedCrossRef
14.
go back to reference Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with lower risk of rheumatoid arthritis in older women: results from the Iowa women’s health study. Arthritis Rheum 50:72–77PubMedCrossRef Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG (2004) Vitamin D intake is inversely associated with lower risk of rheumatoid arthritis in older women: results from the Iowa women’s health study. Arthritis Rheum 50:72–77PubMedCrossRef
15.
go back to reference Nielen MMJ, van Schaardenburg D, van de Stadt RJ et al (2006) Vitamin D deficiency does not increase the risk of rheumatoid arthritis. Arthritis Rheum 11:3719–3724CrossRef Nielen MMJ, van Schaardenburg D, van de Stadt RJ et al (2006) Vitamin D deficiency does not increase the risk of rheumatoid arthritis. Arthritis Rheum 11:3719–3724CrossRef
16.
go back to reference Mouyis M, Ostor AJK, Crisp AJ, Ginawi A, Halsall DJ, Shenker N, Poole KES (2008) Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology 47:1348–1351PubMedCrossRef Mouyis M, Ostor AJK, Crisp AJ, Ginawi A, Halsall DJ, Shenker N, Poole KES (2008) Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology 47:1348–1351PubMedCrossRef
17.
go back to reference Leventis P, Patel S (2008) Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology 47:1617–1621PubMedCrossRef Leventis P, Patel S (2008) Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatology 47:1617–1621PubMedCrossRef
18.
go back to reference Likuni N, Nakajima A, Inoue E et al (2007) What’s in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatology 46:846–848CrossRef Likuni N, Nakajima A, Inoue E et al (2007) What’s in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatology 46:846–848CrossRef
19.
go back to reference Oelzner P, Miller A, Deschner F et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198PubMedCrossRef Oelzner P, Miller A, Deschner F et al (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193–198PubMedCrossRef
20.
go back to reference Kroger H, Penttila IM, Alhava EM (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22:172–177PubMedCrossRef Kroger H, Penttila IM, Alhava EM (1993) Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22:172–177PubMedCrossRef
21.
go back to reference Andjelkovic Z, Vojinovic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456PubMed Andjelkovic Z, Vojinovic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456PubMed
22.
go back to reference Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, Szegedi G, Brun JG, Gesztelyi R, Zeher M, Bodolay E (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68:261–269PubMedCrossRef Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, Szegedi G, Brun JG, Gesztelyi R, Zeher M, Bodolay E (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68:261–269PubMedCrossRef
23.
go back to reference Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134:128–132PubMedCrossRef Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134:128–132PubMedCrossRef
24.
go back to reference Cantorna MT, Hayhes CE, DeLuca HF (1998) 1, 25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72PubMed Cantorna MT, Hayhes CE, DeLuca HF (1998) 1, 25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72PubMed
25.
go back to reference Tetlow LC, Wolley DE (1999) The effects of 1 alpha, 25-dihydroxyvitamin D (3) on matrix metalloproteinase and prostaglandin E (2) production by cells of the rheumatoid lesion. Arthritis Res 1:63–70PubMedCrossRef Tetlow LC, Wolley DE (1999) The effects of 1 alpha, 25-dihydroxyvitamin D (3) on matrix metalloproteinase and prostaglandin E (2) production by cells of the rheumatoid lesion. Arthritis Res 1:63–70PubMedCrossRef
26.
go back to reference Nielen NM, van Schaardenburg D, Lems W et al (2006) Vitamin D deficiency does not increase the risk of rheumatoid arthritis; comment on the article by Merlino et al. Arthritis Rheum 54:3719–3722PubMedCrossRef Nielen NM, van Schaardenburg D, Lems W et al (2006) Vitamin D deficiency does not increase the risk of rheumatoid arthritis; comment on the article by Merlino et al. Arthritis Rheum 54:3719–3722PubMedCrossRef
27.
go back to reference Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed
28.
go back to reference Jones BJ, Twomey PJ (2008) Issues with vitamin D in routine clinical practice. Rheumatology 47:1267–1268PubMedCrossRef Jones BJ, Twomey PJ (2008) Issues with vitamin D in routine clinical practice. Rheumatology 47:1267–1268PubMedCrossRef
Metadata
Title
The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis
Authors
Ayşe Dicle Turhanoğlu
Hayal Güler
Zafer Yönden
Fatma Aslan
Ayhan Mansuroglu
Cahit Ozer
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1393-6

Other articles of this Issue 7/2011

Rheumatology International 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine